Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip S Low

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Blood|May 30, 2009
Where spectrin snuggles with ankyrinPhilip S Low
Molecular Pharmaceutics|October 2, 2007
The optimal strategy for drug targetingPhilip S Low
Journal of Medicinal Chemistry|July 30, 2010
Folate-targeted therapies for cancerWei Xia, Philip S Low
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancersCharity Wayua, Philip S Low
Molecular Pharmaceutics|December 12, 2013
Evaluation of a cholecystokinin 2 receptor-targeted near-infrared dye for fluorescence-guided surgery of cancerCharity Wayua, Philip S Low
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospectsYingjuan Lu, Philip S Low
Advanced Drug Delivery Reviews|September 3, 2002
Folate-mediated delivery of macromolecular anticancer therapeutic agentsYingjuan Lu, Philip S Low
Bioorganic & Medicinal Chemistry Letters|March 15, 2017
Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancerGuo Li, Philip S Low
The Journal of Pharmacy and Pharmacology|March 15, 2003
Targeted immunotherapy of cancer: development of antibody-induced cellular immunityYingjuan Lu, Philip S Low
The Biochemical Journal|July 14, 2006
Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3Haiyan Chu, Philip S Low
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Blood|May 30, 2009
Where spectrin snuggles with ankyrinPhilip S Low
Molecular Pharmaceutics|October 2, 2007
The optimal strategy for drug targetingPhilip S Low
Journal of Medicinal Chemistry|July 30, 2010
Folate-targeted therapies for cancerWei Xia, Philip S Low
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancersCharity Wayua, Philip S Low
Molecular Pharmaceutics|December 12, 2013
Evaluation of a cholecystokinin 2 receptor-targeted near-infrared dye for fluorescence-guided surgery of cancerCharity Wayua, Philip S Low
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2003
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospectsYingjuan Lu, Philip S Low
Advanced Drug Delivery Reviews|September 3, 2002
Folate-mediated delivery of macromolecular anticancer therapeutic agentsYingjuan Lu, Philip S Low
Bioorganic & Medicinal Chemistry Letters|March 15, 2017
Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancerGuo Li, Philip S Low
The Journal of Pharmacy and Pharmacology|March 15, 2003
Targeted immunotherapy of cancer: development of antibody-induced cellular immunityYingjuan Lu, Philip S Low
The Biochemical Journal|July 14, 2006
Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3Haiyan Chu, Philip S Low
Pageof 31